Acurx Pharmaceuticals, Inc.
ACXP· Nasdaq
ACXPAcurx Pharmaceuticals, Inc.
Filed Aug 13, 2021 · 10-Q · 44 days after period end · 0001104659-21-105074
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Net Income | -$4.00M | -$913.36K |
| EPS Diluted | -$0.57 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acurx Pharmaceuticals, Inc. · CIK 1736243 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 13, 2021 · 44 d after period end
